Editas Medicine Inc
NASDAQ:EDIT
Net Margin
Editas Medicine Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
Editas Medicine Inc Competitors
| Country | US |
| Market Cap | 446.4m USD |
| Net Margin |
-196%
|
| Country | US |
| Market Cap | 299.4B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 146.5B USD |
| Net Margin |
24%
|
| Country | US |
| Market Cap | 104.3B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 99.3B USD |
| Net Margin |
30%
|
| Country | AU |
| Market Cap | 133.1B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 83.5B USD |
| Net Margin |
21%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 41.2B USD |
| Net Margin |
-69%
|
| Country | US |
| Market Cap | 28B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 37.2T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Editas Medicine Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Editas Medicine Inc's most recent financial statements, the company has Net Margin of -196.1%.
You don't have any saved screeners yet
